H1N1 ppt and 100 Free full text articles

Parents’  Perceptions of H1N1  Risk Predict Child Vaccinations
Susan T. Heinze,  Ayala Y. Gorodzinsky, Jessica G. Drew,  & W. Hobart Davies
University of Wisconsin-Milwaukee
H1N1.ppt

H1N1  monovalent vaccine and miscarriage
Jonathan  L. Temte, MD/PhD
VaccineSafety.ppt

Influenza The Ultimate Emerging Infectious Disease
Influenza The Ultimate Emerging Infectious Disease.ppt

Influenza  Update for Wisconsin  Laboratories
Pete  Shult, PhD.
Influenza  Update.ppt

Swine Influenza
Swine Influenza.ppt

Viruses,  Viroids, and Prions
by Christine  L. Case
Viruses,  Viroids, and Prions.ppt

Viral Pneumonia
Cheryl  Pirozzi, MD
http://medicine.utah.edu/internalmedicine/Pulmonary/fellowship/presentations/2011/Viral_Pneumonia_cpirozzi.ppt

Replication  of Negative-Sense RNA Viruses (Mutipartite)
RNA Viruses.ppt
H1N1 100 Free full text articles

Characteristics of Hospitalized Children with 2009 Pandemic Influenza A (H1N1): A Multicenter Study in Korea.

Neurologic Complications and Outcomes of Pandemic (H1N1) 2009 in Korean Children.

[Self-reported cases of influenza among Spanish healthcare workers during the 2009 influenza A(H1N1) pandemic.]

Knowledge, attitudes and perceptions of health professionals in relation to A/H1N1 influenza and its vaccine.

Incidence of H1N1 2009 Virus Infection through the Analysis of Paired Plasma Specimens among Blood Donors, France.

Pandemic Influenza A H1N1 2009 Infection versus Vaccination: A Cohort Study Comparing Immune Responses in Pregnancy.

Case-Based Surveillance of Pandemic (H1N1) 2009 in Maebashi City, Japan.

Viral Shedding of 2009 Pandemic H1N1 and Evaluation of Quarantine Recommendations.

Adverse Events following Immunization (AEFI) with the Novel Influenza A (H1N1) 2009 Vaccine: Findings from the National Registry of All Vaccine Recipients and AEFI and the Passive Surveillance System in South Korea.

Pandemic 2009 H1N1 virus infection in children and adults: A cohort study at a single hospital throughout the epidemic.

Mutations in Polymerase Genes Enhanced the Virulence of 2009 Pandemic H1N1 Influenza Virus in Mice.

Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus in Northern Greece.

[Spatial and temporal spread predictability of influenza A H1N1 epidemic in Argentina by the percolation method].

Usefulness of health registries when estimating vaccine effectiveness during the Influenza A(H1N1)pdm09 pandemic in Norway.

Community responses to communication campaigns for Influenza A (H1N1): a focus group study.

A Surveillance System to Reduce Transmission of Pandemic H1N1 (2009) Influenza in a 2600-Bed Medical Center.

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes.

Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.

Health-care providers' preparedness for H1N1/09 influenza prevention and treatment in Dar es Salaam, Tanzania.

Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections.

Sociodemographic Factors and Clinical Conditions Associated to Hospitalization in Influenza A (H1N1) 2009 Virus Infected Patients in Spain, 2009-2010.

US Public Support for Vaccine Donation to Poorer Countries in the 2009 H1N1 Pandemic.

A retrospective cross-sectional study of risk factors and clinical spectrum of children admitted to hospital with pandemic H1N1 influenza as compared to influenza A.

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK.

Pandemic influenza A (H1N1) 2009: risk factors for hospitalization.

Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries.

Superimposed high-frequency jet ventilation combined with continuous positive airway pressure/assisted spontaneous breathing improves oxygenation in patients with H1N1-associated ARDS.

Systemic Corticosteroids and Early Administration of Antiviral Agents for Pneumonia with Acute Wheezing due to Influenza A(H1N1)pdm09 in Japan.

H1N1 influenza virus-associated encephalitis: A case report.

Positive Rates of 2009 Novel Influenza A (H1N1) was High in School-Aged Individuals: Significance in Pandemic Control.

Novel, real-time cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virus.

Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses.

Frequency of D222G and Q223R hemagglutinin mutants of pandemic (H1N1) 2009 influenza virus in Japan between 2009 and 2010.

The new school absentees reporting system for pandemic influenza A/H1N1 2009 infection in Japan.

Risk factors of household transmission of pandemic (H1N1) 2009 among patients treated with antivirals: a prospective study at a primary clinic in Japan.

Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses.

Assessment of border control measures and community containment measures used in Japan during the early stages of Pandemic (H1N1) 2009.

Characteristics of Patients Hospitalized with 2009 H1N1 Influenza in a Tertiary Care Hospital in Southern Saudi Arabia.

Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study.

Acute encephalopathy in childhood associated with novel influenza a h1n1 virus infection: clinical and neuroimaging findings.

Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010-2011 winter seasonal outbreak of influenza A (H1N1) in Spain.

Two cases of exudative retina detachment and uveitis following H1N1 influenza vaccination.

In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.

Report of two rare complications of pandemic influenza A (H1N1).

[Seizures and influenza virus A H1N1 infection in very low birth weight preterm infant.]

Evaluation of pregnancy as a risk factor in the outcomes of influenza A (H1N1)/2009 in women of childbearing age.

Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10.

Coordination and resource-related difficulties encountered by Quebec's public health specialists and infectious diseases/medical microbiologists in the management of A (H1N1) - a mixed-method, exploratory survey.

Influenza, krimfarang and A(H1N1)pdm09.

Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA.

Pandemic (H1N1) 2009 in captive cheetah.

Pandemic (H1N1) 2009 virus circulating in pigs, Guangxi, China.

Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Rapid diagnosis of pandemic (H1N1) 2009 in Cuba.

Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.

The Management of the 2009 pandemic Influenza A H1N1 virus infection.

One-step detection of the 2009 pandemic influenza A(H1N1) virus by the RT-SmartAmp assay and its clinical validation.

Clinical features and risk factors for severe and critical pregnant women with 2009 pandemic H1N1 influenza infection in China. *Zhang PJ, Li XL, Cao B, Yang SG, Liang LR, Gu L, Xu Z, Hu K, Zhang HY, Yan XX, Huang WB, Chen W, Zhang JX, Li LJ, Wang C; for the National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China.

Ischaemic stroke and influenza A H1N1 vaccination: a case report.

[Pandemic influenza A (H1N1) 2009: epidemiology, clinical features and differences with seasonal influenza in Chile].

Distinct regulation of host responses by ERK and JNK MAP kinases in swine macrophages infected with pandemic (H1N1) 2009 influenza virus.

Thoracic CT in 2009 H1N1 influenza.

Thoracic CT scan findings in 2009 Influenza A (H1N1) virus pandemic in Isfahan.

Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.

Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: A survey of local health departments in California.

Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus. *Yang SG, Cao B, Liang LR, Li XL, Xiao YH, Cao ZX, Jia HY, Yu HJ, Xu Z, Gu L, Yang YD, Chen Y, Du WB, Yan XX, Liang ZA, Zhang W, Zhang CL, Chen W, Guo CP, Jiang XL, Yang M, Deng GM, Yu KJ, Hu K, Zou Q, Li LJ, Wang C; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China.

Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.

Perspectives of Pulmonologists on the 2009-2010 H1N1 Vaccination Effort.

H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.

[Life after death: lessons in lung injury physiopathology with necropsies on H1N1 infected patients].

Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.

Pandemic H1N1 influenza.

Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses.

Early detection of pandemic (H1N1) 2009, Bangladesh.

Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing.

Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008.

Spontaneous pneumomediastinum in H1N1 infection.

H1N1 infection in children with hematological malignancies.

Narcolepsy after A/H1N1 vaccination.

Epidemiologic parameters and evaluation of control measure for 2009 novel influenza a (H1N1) in Xiamen, Fujian Province, China.

[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].

Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus.

Acute respiratory distress syndrome induced by a swine 2009 H1N1 variant in mice.

Dynamic patterns of circulating seasonal and pandemic A(H1N1)pdm09 influenza viruses from 2007-2010 in and around Delhi, India.

An adverse event following 2009 H1N1 influenza vaccination: a case of acute disseminated encephalomyelitis.

Clinical characteristics of 2009 pandemic influenza A (H1N1) infection in children and the performance of rapid antigen test.

Involvement of Endocrinologists in the 2009-10 H1N1 Vaccination Effort.

[Influenza A H1N1 respiratory infection: radiologic findings and correlation with clinical outcome in pediatric inpatients. A pediatric hospital experience].

Study of the relationship between socio-demographic characteristics and new influenza A (H1N1).

Factors Affecting Intention among Students to Be Vaccinated against A/H1N1 Influenza: A Health Belief Model Approach.

Safety of Air Travel in H1N1-positive Patient with Hydropneumothorax.

Reactions of Norwegian children with severe egg allergy to an egg-containing influenza A (H1N1) vaccine: a retrospective audit.

Reactive Thrombocytosis in H1N1 Infection.

Receipt of A(H1N1)pdm09 vaccine by prisons and jails - United States, 2009-10 influenza season.

Acute sleep deprivation has no lasting effects on the human antibody titer response following a novel influenza A H1N1 virus vaccination.

Attitudes toward and uptake of H1N1 vaccine among health care workers during the 2009 H1N1 pandemic.

Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study.

Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach.

Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine.

Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus.